Mechanistically, we found that ERCC6L overexpression increased the expression of N-cadherin and decreased the expression of E-cadherin; while ERCC6L knockdown significantly reversed these events, suggesting that ERCC6L affected the malignant biological behavior of GC cells by modulating EMT. Here, CDH2 is linked to gastric cancer.